Head injuries could be a risk factor for developing brain cancer

byUniversity College LondonCredit: Unsplash/CC0 Public DomainResearchers from the UCL Cancer Institute have provided important molecular understanding of how injury may contribute to the develop

Updated on: January 07,2024

Head injuries could be a risk factor for developing brain cancer

byUniversity College LondonCredit: Unsplash/CC0 Public DomainResearchers from the UCL Cancer Institute have provided important molecular understanding of how injury may contribute to the develop

Updated on:January 07,2024

Tackling tumour scar tissue could be key to treating pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainThe first study in the world to take a detailed look

Updated on: April 09,2024

Tackling tumour scar tissue could be key to treating pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainThe first study in the world to take a detailed look

Updated on:April 09,2024

Living alone doesn't have to mean being lonely, says study

by Sebastian Hollstein, Friedrich-Schiller-Universität JenaLiving alone does not necessarily mean isolation and loneliness, according to a recent study by the University of Jena. Credit: Jens Meyer/Un

Updated on: May 21,2024

Living alone doesn't have to mean being lonely, says study

by Sebastian Hollstein, Friedrich-Schiller-Universität JenaLiving alone does not necessarily mean isolation and loneliness, according to a recent study by the University of Jena. Credit: Jens Meyer/Un

Updated on:May 21,2024

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

Updated on: January 10,2024

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

Updated on:January 10,2024

Hunting brain cancer cells: Neuronal and tumorigenic boundaries of glioblastoma plasticity

byFlinders UniversityGlioblastoma tumor cells express aberrant neuronal signatures and differentiate along a neurodevelopmental trajectory. (A) Healthy neuronal cells transform to a malignant ph

Updated on: January 15,2024

Hunting brain cancer cells: Neuronal and tumorigenic boundaries of glioblastoma plasticity

byFlinders UniversityGlioblastoma tumor cells express aberrant neuronal signatures and differentiate along a neurodevelopmental trajectory. (A) Healthy neuronal cells transform to a malignant ph

Updated on:January 15,2024

Percentage of breast cancer survivors in Canada doubles over past 15 years, study finds

by Jelena Damjanovic,University of Toronto(A) Distribution of breast cancer survivors by current (2022) age group. (B) Prevalence of net survivors of breast cancer within Canadian population by

Updated on: January 23,2024

Percentage of breast cancer survivors in Canada doubles over past 15 years, study finds

by Jelena Damjanovic,University of Toronto(A) Distribution of breast cancer survivors by current (2022) age group. (B) Prevalence of net survivors of breast cancer within Canadian population by

Updated on:January 23,2024

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion

Updated on: May 13,2024

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion

Updated on:May 13,2024

Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

byUniversity of OxfordSpleen sections from mito-QC mice immunized with SRBC and analyzed on day 12. Scale bar, 50 μm. Representative of three independent experiments. Credit:Nature Immunol

Updated on: January 10,2024

Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

byUniversity of OxfordSpleen sections from mito-QC mice immunized with SRBC and analyzed on day 12. Scale bar, 50 μm. Representative of three independent experiments. Credit:Nature Immunol

Updated on:January 10,2024

'I'm not going to be cured'. How breast cancer awareness and support sidelines people with metastatic disease

by Sophie Lewis, Andrea Smith and Katherine Kenny,The ConversationCredit: AI-generated imageThere have been incredibleadvancesin breast cancer diagnosis and treatment in recent years

Updated on: March 14,2024

'I'm not going to be cured'. How breast cancer awareness and support sidelines people with metastatic disease

by Sophie Lewis, Andrea Smith and Katherine Kenny,The ConversationCredit: AI-generated imageThere have been incredibleadvancesin breast cancer diagnosis and treatment in recent years

Updated on:March 14,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on: January 28,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on:January 28,2024

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on: September 27,2024

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on:September 27,2024

Activation of a distinct genetic pathway can slow the progress of metastatic breast cancer

by Olivia Newton-John Cancer Research InstituteImmunofluorescent staining reveals activation of the BMP-Smad signaling pathway in metastatic breast cancer cells in response to BMP4 stimulation (left p

Updated on: December 20,2023

Activation of a distinct genetic pathway can slow the progress of metastatic breast cancer

by Olivia Newton-John Cancer Research InstituteImmunofluorescent staining reveals activation of the BMP-Smad signaling pathway in metastatic breast cancer cells in response to BMP4 stimulation (left p

Updated on:December 20,2023